nach oben

Erschienen in:

2025 | OriginalPaper | Buchkapitel

35. Adnexe

verfasst von : Priv.-Doz. Dr. med. Ute Germer, Prof. Dr. med. Markus Hoopmann

Erschienen in: Ultraschalldiagnostik in Geburtshilfe und Gynäkologie

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die sonographische Untersuchung von Uterus und Adnexen ist eine Standardmethode zur Abklärung von Symptomen sowie unklaren Raumforderungen und gelingt zuverlässig mit der Transvaginalsonographie (TVS). Dabei sollten formelle Kriterien bei der Befunderhebung und -dokumentation eingehalten werden. Bei der Differenzialdiagnose von Läsionen an den Ovarien gelingt erfahrenen Untersuchern bei 90 % der Tumoren durch Wiedererkennung von spezifischen sonomorphologischen Bildern eine zutreffende Dignitätseinschätzung. Die Ergebnisse der multimodalen Screeningstudien für das Ovarialkarzinom belegen eine hohe Entdeckungsrate für das Ovarialkarzinom, jedoch ist der erhoffte Überlebensvorteil zweifelhaft. Im Risikokollektiv gelingt es auch durch ein engmaschiges simultanes Screening mittels Tumormarker und TVS nicht, Tuben- und Ovarialkarzinome zuverlässig in frühen Erkrankungsstadien zu entdecken. Die Kombination von transvaginaler und transabdomineller Sonographie ist als präoperative Stagingmethode beim Ovarialkarzinom ähnlich gut geeignet, eine Peritonealkarzinose zu diagnostizieren wie die Computertomographie oder die Kernspintomographie.

Vorheriges Kapitel Uterus

Nächstes Kapitel Ultraschall des Beckenbodens

Alcázar JL, Jurado M (2011) Three-dimensional ultrasound for assessing women with gynecological cancer: a systematic review. Gynecol Oncol 120:340–346PubMedCrossRef

Alcázar JL, Pascual MA, Graupera B, Aubá M, Errasti T, Olartecoechea B, Ruiz-Zambrana A, Hereter L, Ajossa S, Guerriero S (2016) External validation of IOTA simple descriptors and simple rules for classifying adnexal masses. Ultrasound Obstet Gynecol 48:397–402.PubMedCrossRef

Andersen MR, Lowe KA, Goff BA (2014) Value of symptom-triggered diagnostic evaluation for ovarian cancer. Obstet Gynecol 123:73–79PubMedPubMedCentralCrossRef

Andreotti RF, Timmerman D, Strachowski LM, Froyman W, Benacerraf BR, Bennett GL, Bourne T, Brown DL, Coleman BG, Frates MC, Goldstein SR, Hamper UM, Horrow MM, Hernanz-Schulman M, Reinhold C, Rose SL, Whitcomb BP, Wolfman WL, Glanc P (2019) O-RADS US risk stratification and management system: a consensus guideline from the ACR ovarian-Adnexal reporting and data system committee. Radiology 294:191150.

Araujo KG, Jales RM, Pereira PN, Yoshida A, Andrade LDA, Sarian LO, Derchain S (2017) Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center. Ultrasound Obstet Gynecol 49:778–783PubMedCrossRef

AWMF Leitlinie (2024) (AWMF-Registernummer: 032-035OL) S3-Leitlinie Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren, Langversion 6.0 (AWMF-Registernummer: 032-035OL). https://www.leitlinienprogramm-onkologie.de/leitlinien/ovarialkarzinom/

Buys SS, Patridge E, Greene MH, Project Team PLCO et al (2005) Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLOC) cancer screening trial. Am J Obstet Gynecol 193:1630–1639PubMedCrossRef

Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B, Crawford ED, Church TR, Andriole GL, Weissfeld JL, Fouad MN, Chia D, O’Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hartge P, Pinsky PF, Zhu CS, Izmirlian G, Kramer BS, Miller AB, Xu JL, Prorok PC, Gohagan JK, Berg CD, Project Team PLCO (2011) Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial. JAMA 305:2295–2303PubMedCrossRef

Calster BV, Hoorde KV, Valentin L, Testa AC, Fischerova D, Holsbeke CV, Savelli L, Franchi D, Epstein E, Kaijser J, Belle VV, Czekierdowski A, Guerriero S, Fruscio R, Lanzani C, Scala F, Bourne T, Timmerman D, Group IOTA (2014) Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ 349:g5920PubMedPubMedCentralCrossRef

Calster BV et al (2020) Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study. BMJ 370:m2614PubMedPubMedCentralCrossRef

Campbell S, Bhan V, Royston P, Whitehead MI, Collins WP (1989) Transabdominal ultrasound screening for ovarian cancer. Brit Med J 299:1363–1367PubMedPubMedCentralCrossRef

Doroudi M, Kramer BS, Pinsky PF (2017) The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian Cancer screening trial: performance and complications. J Med Screen 24:220–222PubMedCrossRef

Ebell MH, Culp M, Lastinger K, Dasigi T (2015) A systematic review of the bimanual examination as a test for ovarian cancer. Am J Prev Med 48:350–356PubMedCrossRef

Fischerova D (2011) Ultrasound scanning of the pelvis and abdomen for staging of gynecological tumors: a review. Ultrasound Obstet Gynecol 38:246–266PubMedCrossRef

Fischerova D, Cibula D (2015) Ultrasound in gynecological cancer: is it time for re-evaluation of its uses? Curr Oncol Rep 17:28PubMedCrossRef

Fischerova D, Zikan M, Semeradova I, Slama J, Kocian R, Dundr P, Nemejcova K, Burgetova A, Dusek L, Cibula D (2017) Ultrasound in preoperative assessment of pelvic and abdominal spread in patients with ovarian cancer: a prospective study. Ultrasound Obstet Gynecol 49:263–274PubMedCrossRef

Fischerova D, Pinto P, Burgetova A, Masek M, Slama J, Kocian R, Frühauf F, Zikan M, Dusek L, Dundr P, Cibula D (2022) Preoperative staging of ovarian cancer: comparison between ultrasound, CT and whole-body diffusion-weighted MRI (ISAAC study). Ultrasound Obst Gyn 59:248–262CrossRef

Fishman DA, Leeber C, Blank SV, Shulmann L, Singh D, Bozorgi K, Tamura R, Timor-Tritsch I, Schwartz PE (2005) The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. Am J Obstet Gynecol 192:1214–1222PubMedCrossRef

Fleischer A (2002) Sonographic assessment of the morphology and vascularity of ovarian masses. Ultrasound Q 18:81–88PubMedCrossRef

Froyman W, Landolfo C, Cock BD, Wynants L, Sladkevicius P, Testa AC, Holsbeke CV, Domali E, Fruscio R, Epstein E, dos Bernardo MJS, Franchi D, Kudla MJ, Chiappa V, Alcazar JL, Leone FPG, Buonomo F, Hochberg L, Coccia ME, Guerriero S, Deo N, Jokubkiene L, Kaijser J, Coosemans A, Vergote I, Verbakel JY, Bourne T, Calster BV, Valentin L, Timmerman D (2019) Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study. Lancet Oncol 20:448–458PubMedCrossRef

Fung MF, Bryson P, Johnston M, Chambers A, Cancer Care Ontario Practice Guidelines Initiative Gynecology Cancer Disease Site Group (2004) Screening postmenopausal women for ovarian cancer: a systematic review. J Obstet Gynaecol Can 26:717–728PubMedCrossRef

Gatreh-Samani F, Tarzamni MK, Olad-Sahebmadarek E, Dastranj A, Afrough A (2011) Accuracy of 64-multidetector computed tomography in diagnosis of adnexal tumors. J Ovarian Res 17:4–15

Gaurilcikas A, Gedgaudaite M, Cizauskas A, Atstupenaite V, Paskauskas S, Gaurilcikiene D, Birzietis T, Vaitkiene D, Nadisauskiene RJ (2020) Performance of the IOTA ADNEX Model on Selected Group of Patients with Borderline Ovarian Tumours. Ann Univ Mariae Curie Sklodowska [Med] 56:690.

Germer U (2007a) Dopplerultraschall. In: Gyn update. Springer, Heidelberg

Germer U (2007b) 3D-Ultraschall. In: Gyn update. Springer, Heidelberg

Gilbert L, Basso O, Sampalis J, Karp I, Martins C, Feng J, Piedimonte S, Quintal L, Ramanakumar AV, Takefman J, Grigorie MS, Artho G, Krishnamurthy S, DOvE Study Group (2012) Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project. Lancet Oncol 13:285–291PubMedCrossRef

Grab D, Merz E, Prömpeler H, Eichhorn KH, Germer U, Osmers R, Strauss A, Wisser J, Dürr W (2011) Standards for ultrasound in gynecology. Ultraschall Med 32:415–417PubMedCrossRef

Grab D, Merz E, Eichhorn K-H, Tutschek B, Kagan KO, Heling K-S, Faber R, Klaritsch P, Rempen A, Kähler C, Henrich W, Manegold-Brauer G, Helmy S, Hoopmann M (2023) Basic gynecologic ultrasound examination (level I): DEGUM, ÖGUM, and SGUM recommendations. Ultraschall Med 44:151–161PubMedCrossRef

Henrich W, Fotopoulou C, Fuchs I (2007) Value of preoperative transvaginal sonography (TVS) in the description of tumor pattern in ovarian cancer patients: results of a prospective study. Anticancer Res 27:4289–4294PubMed

Hensley ML, Robson ME, Kauff ND, Korytowsky B, Castiel M, Ostroff J, Hurley K, Hann LE, Colon J, Spriggs D (2003) Pre- and postmenopausal women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life. Gynecol Oncol 89:440–406PubMedCrossRef

Hoopmann M, Tutschek B, Merz E, Eichhorn K-H, Kagan KO, Heling K-S, Faber R, Rempen A, Kaehler C, Manegold-Brauer G, Helmy S, Klaritsch P, Grab D (2021) Quality Requirements for gynecological ultrasound examinations of DEGUM level II – Recommendations of the Sections/Working Groups Gynecology and Obstetrics of DEGUM, ÖGUM and SGUM. Ultraschall Med 43:146–158PubMed

Huang X, Wang Z, Zhang M, Luo H (2021) Diagnostic accuracy of the ADNEX model for ovarian cancer at the 15 % cut-off value: a systematic review and meta-analysis. Front Oncol 11:684257PubMedPubMedCentralCrossRef

Jacobs I, Oram D (1988) Screening for ovarian cancer. Biomed Pharmacother 42:589–596PubMed

Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG (1990) A risk of malignancy index incorporating CA125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol 97:922–929PubMedCrossRef

Jacobs I, Skates S, MacDonald N, Menon U, Rosenthal AN, Davies AP, Woolas R, Jeyarajah AR, Sibley K, Lowe DG, Oram DH (1999) Screening for ovarian cancer. A pilot randomised controlled trial. Lancet 353:1207–1209PubMedCrossRef

Jacobs I, Mackay J, Menon U, Skates SJ, Rosenthal AN, Fraser L (2006) Familial ovarian screening – effective or ineffective? Br J Canc 95:1124CrossRef

Jacobs I, Menon U (2011) Can ovarian cancer screening save lives? The question remains unanswered. Obstet Gynecol 118:1209–1211PubMedCrossRef

Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, Amso NN, Apostolidou S, Benjamin E, Cruickshank D, Crump DN, Davies SK, Dawnay A, Dobbs S, Fletcher G, Ford J, Godfrey K, Gunu R, Habib M, Hallett R, Herod J, Jenkins H, Karpinskyj C, Leeson S, Lewis SJ, Liston WR, Lopes A, Mould T, Murdoch J, Oram D, Rabideau DJ, Reynolds K, Scott I, Seif MW, Sharma A, Singh N, Taylor J, Warburton F, Widschwendter M, Williamson K, Woolas R, Fallowfield L, McGuire AJ, Campbell S, Parmar M, Skates SJ (2016) Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet 387:945–956 (Erratum in: Lancet 2016; 387: 944)PubMedPubMedCentralCrossRef

Jurkovic D, Mavrelos D (2007) Catch me if you scan: ultrasound diagnosis of ectopic pregnancy. Ultrasound Obstet Gynecol Rev 30:1–7CrossRef

Kaijser J, Sayasneh A, Van Hoorde K, Ghaem-Maghami S, Bourne T, Timmerman D, Van Calster B (2014) Presurgical diagnosis of adnexal tumors using mathematical models and scoring systems: a systematic review and meta-analysis. Hum Reprod Update 20:449–462PubMedCrossRef

Keckstein J, Hoopmann M, Merz E, Grab D, Weichert J, Helmy-Bader S, Wölfler M, Bajka M, Mechsner S, Schäfer S, Krentel H, Hudelist G (2022) Expert opinion on the use of transvaginal sonography for presurgical staging and classification of endometriosis. Arch Gynecol Obstet 307:5–19PubMedPubMedCentralCrossRef

Kinkel K, Hricak H, Lu Y, Tsuda K, Filly RA (2000) Ultrasound characterization of ovarian masses. A meta-analysis. Radiology 217:803–811PubMedCrossRef

Kobayashi H, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R, Kanayama S, Shigetomi H, Haruta S, Tsuji Y, Ueda S, Kitanaka T (2008) A randomized study of screening for ovarian cancer: a multicenter study in Japan. Int J Gynecol Cancer 18:414–420PubMedCrossRef

Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2016) S3-Leitlinie Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren, Langversion 2.0 2016, AWMF-Registernummer: 032/035OL. http://leitlinienprogramm-onkologie.de/Ovarialkarzinom.61.0.html

Maymon R, Herman A, Ariely S, Dreazen E, Buckovsky I, Weinraub Z (2000) Three-dimensional vaginal sonography in obstetrics and gynecology. Hum Reprod Update 6:475–478PubMedCrossRef

Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, Lewis S, Davies S, Philpott S, Lopes A, Godfrey K, Oram D, Herod J, Williamson K, Seif MW, Scott I, Mould T, Woolas R, Murdoch J, Dobbs S, Amso NN, Leeson S, Cruickshank D, McGuire A, Campbell S, Fallowfield L, Singh N, Dawnay A, Skates SJ, Parmar M, Jacobs I (2009) Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trail von Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 10:327–340PubMedCrossRef

Menon U, Gentry-Maharaj A, Burnell M, Singh N, Ryan A, Karpinskyj C, Carlino G, Taylor J, Massingham SK, Raikou M, Kalsi JK, Woolas R, Manchanda R, Arora R, Casey L, Dawnay A, Dobbs S, Leeson S, Mould T, Seif MW, Sharma A, Williamson K, Liu Y, Fallowfield L, McGuire AJ, Campbell S, Skates SJ, Jacobs IJ, Parmar M (2021) Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet 397:2182–2193PubMedPubMedCentralCrossRef

Menon U, Gentry-Maharaj A, Burnell M, Ryan A, Kalsi JK, Singh N, Dawnay A, Fallowfield L, McGuire AJ, Campbell S, Skates SJ, Parmar M, Jacobs IJ (2023) Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial. Health Technol Assess:1–81

Merz E, Miric-Tesanic D, Bahlmann F, Weber G, Wellek S (1996) Sonographic size of uterus and ovaries in pre- and postmenopausal women. Ultrasound Obstet Gynecol 7:38–42PubMedCrossRef

Meys E, Rutten I, Kruitwagen R, Slangen B, Lambrechts S, Mertens H, Nolting E, Boskamp D, Gorp TV (2017) Simple rules, not so simple: the use of international ovarian tumor analysis (IOTA) terminology and simple rules in inexperienced hands in a prospective multicenter cohort study. Ultraschall Medizin 38:633–641CrossRef

Meys EMJ, Kaijser J, Kruitwagen RFPM, Slangen BFM, Calster BV, Aertgeerts B, Verbakel JY, Timmerman D, Gorp TV (2016) Subjective assessment versus ultrasound models to diagnose ovarian cancer: a systematic review and meta-analysis. Eur J Cancer 58:17–29PubMedCrossRef

Michielsen K, Vergote I, Op de Beeck K, Amant F, Leunen K, Moerman P, Deroose C, Souverijns G, Dymarkowski S, De Keyzer F, Vandecaveye V (2014) Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. Eur Radiol 24:889–901PubMedCrossRef

Modesitt SC, Pavlik EJ, Ueland FR, DePriest PD, Kryscio RJ, van Nagell JR Jr (2003) Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter. Obstet Gynecol 102:594–599PubMed

National Collaborating Centre for Cancer (UK) (2011) Ovarian cancer: the recognition and initial management of ovarian cancer. National Collaborating Centre for Cancer, Cardiff

Nisenblat V, Bossuyt PM, Farquhar C, Johnson N, Hull ML (2016) Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2:CD009591PubMed

Nunes N, Ambler G, Hoo W-L, Naftalin J, Foo X, Widschwendter M, Jurkovic D (2013) A prospective validation of the IOTA logistic regression models (LR1 and LR2) in comparison to subjective pattern recognition for the diagnosis of ovarian cancer. Int J Gynecol Cancer 23:1583–1589PubMedCrossRef

Nunes N, Ambler G, Foo X, Naftalin J, Widschwendter M, Jurkovic D (2014) Use of IOTA simple rules for diagnosis of ovarian cancer: meta-analysis. Ultrasound Obstet Gynecol 44:503–514CrossRefPubMed

Nunes N, Ambler G, Foo X, Naftalin J, Derdelis G, Widschwendter M, Jurkovic D (2017) Comparison of two protocols for the management of asymptomatic postmenopausal women with adnexal tumours – a randomised controlled trial of RMI/RCOG vs Simple Rules. Br J Cancer 116:584–591PubMedPubMedCentralCrossRef

Oei AL, Massuger LF, Bulten J, Ligtenberg MJ, Hoogerbrugge N, de Hullu JA (2006) Surveillance of women at high risk for hereditary ovarian cancer is inefficient. Br J Canc 95:814–819CrossRef

Ore RM, Baldwin L, Woolum D, Elliott E, Wijers C, Chen CY, Miller RW, DeSimone CP, Ueland FR, Kryscio RJ, Nagell JR, Pavlik EJ (2017) Symptoms relevant to surveillance for ovarian cancer. Diagnostics 7:E18CrossRef

Outwater EK, Siegelman ES, Hunt JL (2001) Ovarian teratomas: tumor types and imaging characteristics. Radiographics 21:475–490PubMedCrossRef

Paladini D, Testa A, Van Holsbeke C, Mancari R, Timmerman D, Valentin L (2009) Imaging in gynecological disease: clinical and ultrasound characteristics in fibroma and fibrothecoma of the ovary. Ultrasound Obstet Gynecol 34:188–195PubMedCrossRef

Pinsky PF, Yu K, Kramer BS, Black A, Buys SS, Partridge E, Gohagan J, Berg CD, Prorok PC (2016) Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up. Gynecol Oncol 143:270–275PubMedPubMedCentralCrossRef

Piovano E, Cavallero C, Fuso L, Viora E, Ferrero A, Gregori G, Grillo C, Macchi C, Mengozzi G, Mitidieri M, Pagano E, Zola P (2017) Diagnostic accuracy and cost-effectiveness of different strategies to triage women with adnexal masses: a prospective study: Triaging adnexal masses. Ultrasound Obst Gyn 50:395–403CrossRef

Robert Koch-Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (2015) Krebs in Deutschland 2011/2012, 10. Aufl. Robert Koch-Institut Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V., Berlin

Rosenthal AN, Fraser L, Manchanda R, Badman P, Philpott S, Mozersky J, Hadwin R, Cafferty FH, Benjamin E, Singh N, Evans DG, Eccles DM, Skates SJ, Mackay J, Menon U, Jacobs IJ (2013) Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule. J Clin Oncol 31:49–57PubMedCrossRef

Rosenthal AN, Fraser LSM, Philpott S, Manchanda R, Burnell M, Badman P, Hadwin R, Rizzuto I, Benjamin E, Singh N, Evans DG, Eccles DM, Ryan A, Liston R, Dawnay A, Ford J, Gunu R, Mackay J, Skates SJ, Menon U, Jacobs IJ, United Kingdom Familial Ovarian Cancer Screening Study collaborators (2017) Evidence of stage shift in women diagnosed with ovarian cancer during phase II of the United Kingdom Familial Ovarian Cancer Screening Study. J Clin Oncol 35:1411–1420PubMedPubMedCentralCrossRef

Saunders BA, Podzielinski I, Ware RA, Goodrich S, DeSimone CP, Ueland FR, Seamon L, Ubellacker J, Pavlik EJ, Kryscio RJ, van Nagell JR Jr (2010) Risk of malignancy in sonographically confirmed septated cystic ovarian tumors. Gynecol Oncol 118:278–282PubMedCrossRef

Savelli L, de Iaco P, Ghi T, Bovicelli L, Rosati F, Cacciatore B (2004) Transvaginal sonographic appearance of peritoneal pseudocysts. Ultrasound Obstet Gynecol 23:284–288PubMedCrossRef

Savelli L, De Iaco P, Ceccaroni M (2005) Transvaginal sonographic features of peritoneal carcinomatosis. Ultrasound Obstet Gynecol 26:552–557PubMedCrossRef

Savelli L, Ghi T, De Iaco P, Ceccaroni M, Venturoli S, Cacciatore B (2006) Paraovarian/paratubal cysts: comparison of transvaginal sonographic and pathological findings to establish diagnostic criteria. Ultrasound Obstet Gynecol 28:330–334PubMedCrossRef

Sayasneh A, Ferrara L, Cock BD, Saso S, Al-Memar M, Johnson S, Kaijser J, Carvalho J, Husicka R, Smith A, Stalder C, Blanco MC, Ettore G, Calster BV, Timmerman D, Bourne T (2016) Evaluating the risk of ovarian cancer before surgery using the ADNEX model: a multicentre external validation study. Brit J Cancer 115:542–548PubMedPubMedCentralCrossRef

Sharma A, Gentry-Maharaj A, Burnell M, Campbell S, Amso NN, Seif MW, Fletcher G, Brunell C, Turner G, Rangar R, Ryan A, Jacobs I, Menon U (2012) Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a prospective cohort study. BJOG 119:207–219PubMedCrossRef

Sharma A, Burnell M, Gentry-Maharaj A, Campbell S, Amso NN, Seif MW, Fletcher G, Brunell C, Turner G, Rangar R, Ryan A, Jacobs I, Menon U (2016) Quality assurance and its impact on ovarian visualization rates in the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Ultrasound Obstet Gynecol 47:228–235PubMedPubMedCentralCrossRef

Skates SJ, Greene MH, Buys SS, Mai PL, Brown PH, Piedmonte M, Rodriguez GC, Schorge JO, Sherman M, Daly MB, Rutherford TJ, Brewster WR, O’Malley DM, Partridge EE, Boggess J, Drescher CW, Isaacs C, Berchuck A, Domchek SM, Davidson SA, Edwards RP, Elg SA, Wakeley K, Phillips KA, Armstrong DK, Horowitz IR, Fabian CJ, Walker J, Sluss PM, Welch WR, Minasian L, Horick N, Kasten CH, Nayfield S, Alberts DS, Finkelstein DM, Lu K (2017) Early detection of ovarian cancer using the risk of ovarian cancer algorithm with frequent CA125 testing in women at increased familial risk – combined results from two screening trials. Clin Cancer Res 23:3628–3637PubMedPubMedCentralCrossRef

Sohaib SA, Mills TD, Sahdev A, Webb JA, Vantrappen PO, Jacobs IJ, Reznek RH (2005) The role of magnetic resonance imaging and ultrasound in patients with adnexal mass. Clin Radiol 60:340–348PubMedCrossRef

Sokalska A, Valentin L (2008) Changes in ultrasound morphology of the uterus and ovaries during the menopausal transition and early postmenopause: a 4-year longitudinal study. Ultrasound Obstet Gynecol 31:210–217PubMedCrossRef

Sokalska A, Timmerman D, Testa AC, Holsbeke CV, Lissoni AA, Leone FPG, Jurkovic D, Valentin L (2009) Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses. Ultrasound Obstet Gynecol 34:462–470PubMedCrossRef

Sun Z, Gilbert L, Ciampi A, Kaufman JS, Basso O (2016) Estimating the prevalence of ovarian cancer symptoms in women aged 50 years or older: problems and possibilities. Am J Epidemiol 184:670–680PubMedPubMedCentralCrossRef

Tailor A, Bourne TH, Campbell S, Okokon E, Dew T, Collins WP (2006) Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study. Ultrasound Obstet Gynecol 21:378–385CrossRef

Taylor A, Jurkovic D, Bourne TH, Collins WP, Campbell S (1997) Sonographic prediction of malignancy in adnexal masses using multivariate logistic regression analysis. Ultrasound Obstet Gynecol 10:41–47CrossRef

Testa A, Kaijser J, Wynants L, Fischerova D, Holsbeke CV, Franchi D, Savelli L, Epstein E, Czekierdowski A, Guerriero S, Fruscio R, Leone FPG, Vergote I, Bourne T, Valentin L, Calster BV, Timmerman D (2014) Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study. Br J Cancer 111:680–688CrossRefPubMedPubMedCentral

Testa AC, Ferrandina G, Timmerman D, Savelli L, Ludovisi M, Van Holsbeke C, Malaggese M, Scambia G, Valentin L (2007) Imaging in gynecological disease : ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor. Ultrasound Obstet Gynecol 29:505–511PubMedCrossRef

Testa AC, Ludovisi M, Mascilini F, Di Legge A, Malaggese M, Fagotti A, Fanfani F, Salerno MG, Ercoli A, Scambia G, Ferrandina G (2012) Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study. Ultrasound Obstet Gynecol 39:99–105PubMedCrossRef

Timmerman D, Bourne TH, Taylor A, Collins WP, Verrelst H, Vandenberghe K, Vergote I (1999) A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: the development of a new logistic regression model. Am J Obstet Gynecol 181:57–65PubMedCrossRef

Timmerman D, Valentin L, Bourne TH, Collins WP, Verrelst H, Vergote I (2000) Terms, definitions, and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group. Ultrasound Obstet Gynecol 16:500–505PubMedCrossRef

Timmerman D, Ameye L, Fischerova D, Epstein E, Melis GB, Guerriero S, Holsbeke CV, Savelli L, Fruscio R, Lissoni AA, Testa AC, Veldman J, Vergote I, Huffel SV, Bourne T, Valentin L (2010) Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ 341:c6839PubMedPubMedCentralCrossRef

Timmerman D, Calster BV, Testa A, Savelli L, Fischerova D, Froyman W, Wynants L, Holsbeke CV, Epstein E, Franchi D, Kaijser J, Czekierdowski A, Guerriero S, Fruscio R, Leone FPG, Rossi A, Landolfo C, Vergote I, Bourne T, Valentin L (2016) Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group. Am J Obstet Gynecol 214:424–437PubMedCrossRef

Timmerman D, Planchamp F, Bourne T, Landolfo C, Bois A, Chiva L, Cibula D, Concin N, Fischerova D, Froyman W, Gallardo G, Lemley B, Loft A, Mereu L, Morice P, Querleu D, Testa A, Vergote I, Vandecaveye V, Scambia G, Fotopoulou C (2021) ESGO/ISUOG/IOTA/ESGE Consensus statements on the pre-operative diagnosis of ovarian tumours. Ultrasound Obstet Gynecol 58:148–168PubMedCrossRef

Tingulstad S, Hagen B, Skjeldestad FE, Onsrud M, Kiserud T, Halvorsen T, Nustad K (1996) Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol 103:826–831PubMedCrossRef

Tsili AC, Tsampoulas C, Charisiadi A, Kalef-Ezra J, Dousias V, Paraskevaidis E, Efremidis SC (2008) Adnexal masses: accuracy of detection and differentiation with multidetector computed tomography. Gynecol Oncol 110:22–31PubMedCrossRef

Valentin L (2006) Imaging in gynecology. Best Pract Res Clin Obstet Gynecol 20:881–906CrossRef

Valentin L, Hagen B, Tingulstad S, Eik-Nes S (2001) Comparison of “pattern recognition” and logistic regression models for discrimination between benign and malignant pelvic masses: a prospective cross validation. Ultrasound Obstet Gynecol 18:357–365PubMedCrossRef

Valentin L, Ameye L, Jurkovic D, Metzger U, Lecurus F, Van Huffel S, Timmermann D (2006) Which extrauterine pelvic masses are difficult to correctly classify as benign or malignant on the basis of ultrasound findings and is there a way of making a correct diagnosis? Ultrasound Obstet Gynecol 27:438–444PubMedCrossRef

Valentin L, Ameye L, Savelli L, Fruscio R, Leone FP, Czekierdowski A, Lissoni AA, Fischerova D, Guerriero S, Van Holsbeke C, Van Huffel S, Timmerman D (2011) Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help. Ultrasound Obstet Gynecol 38:456–465PubMedCrossRef

Valentin L, Ameye L, Franchi D, Guerriero S, Jurkovic D, Savelli L, Fischerova D, Lissoni A, Van Holsbeke C, Fruscio R, Van Huffel S, Testa A, Timmerman D (2013) Risk of malignancy in unilocular cysts: a study of 1148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature. Ultrasound Obstet Gynecol 41:80–89PubMedCrossRef

Van Calster B, Van Hoorde K, Froyman W, Kaijser J, Wynants L, Landolfo C, Anthoulakis C, Vergote I, Bourne T, Timmerman D (2015) Practical guidance for applying the ADNEX model from the IOTA group to discriminate between different subtypes of adnexal tumors. Facts Views Vis Obgyn 7:32–41PubMedPubMedCentral

Van Holsbeke C, Domali E, Holland TK, Achten R, Testa AC, Valentin L, Jurkovic D, Moerman P, Timmerman D (2008) Imaging of gynecological disease: clinical and ultrasound characteristics of granulosa cell tumors of the ovary. Ultrasound Obstet Gynecol 31:450–456PubMedCrossRef

Van Holsbeke C, Van Calster B, Testa AC, Domali E, Lu C, Van Huffel S, Valentin L, Timmerman D (2009) Prospective internal validation of mathematical models to predict malignancy in adnexal masses: results from the international ovarian tumor analysis study. Clin Cancer Res 15:684–691PubMedCrossRef

Van Holsbeke C, Van Calster B, Guerriero S, Savelli L, Paladini D, Lissoni AA, Czekierdowski A, Fischerova D, Zhang J, Mestdagh G, Testa AC, Bourne T, Valentin L, Timmerman D (2010) Endometriomas: their ultrasound characteristics. Ultrasound Obstet Gynecol 35:730–740PubMedCrossRef

Van Holsbeke C, Van Calster B, Bourne T, Ajossa S, Testa AC, Guerriero S, Fruscio R, Lissoni AA, Czekierdowski A, Savelli L, Van Huffel S, Valentin L, Timmerman D (2012) External validation of diagnostic models to estimate the risk of malignancy in adnexal masses. Clin Cancer Res 18:815–825PubMedCrossRef

Van Nagell J Jr, DePriest PD, Reedy MB, Gallion HH, Ueland FR, Pavlik EJ, Kryscio RJ (2000) The efficiacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol 77:350–356PubMedCrossRef

Van Nagell JR Jr, Miller RW, DeSimone CP, Ueland FR, Podzielinski I, Goodrich ST, Elder JW, Huang B, Kryscio RJ, Pavlik EJ (2011) Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening. Obstet Gynecol 118:1212–1221PubMedCrossRef

Weinberger V, Fischerova D, Semeradova I, Slama J, Dundr P, Dusek L, Cibula D, Zikan M (2016) Prospective evaluation of ultrasound accuracy in the detection of pelvic carcinomatosis in patients with ovarian cancer. Ultrasound Med Biol 42:2196–2202PubMedCrossRef

Zurawski VR, Knapp RC, Einhorn N, Kenemans P, Mortel R, Ohmi K, Bast RC Jr, Ritts RE Jr, Malkasian G (1988) An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma. Gynecol Oncol 30:7–14PubMedCrossRef

Titel: Adnexe
verfasst von: Priv.-Doz. Dr. med. Ute Germer
Prof. Dr. med. Markus Hoopmann
Verlag: Springer Berlin Heidelberg
Buch: Ultraschalldiagnostik in Geburtshilfe und Gynäkologie
Print ISBN: 978-3-662-67372-0

Electronic ISBN: 978-3-662-67373-7

Copyright-Jahr: 2025
DOI: https://doi.org/10.1007/978-3-662-67373-7_35

Springerpflege

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten